LGALS3 and obesity disorder: We here report for the first time that Gal-3 can modulate some of the metabolic consequences of obesity, since the inhibitor of Gal-3 activity MCP reduced cardiac lipotoxicity and ameliorated the mitochondrial damage observed in the heart of obese rats.